Healthcare / Health Information ServicesTokyo
$2570.00
-20.00 (-0.78%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $685.0M · quality 79.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
57/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$6.2B
P/E
9.1x
↓EV/EBITDA
2.0x
↓ROE
21.2%
↑Gross Margin
39.0%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+13.8%
FCF CAGR
+15.5%
FCF margin
20.4%
FCF / Net income
1.19x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.33B · net income $912.9M · FCF $1.09B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.33B | $5.33B | $4.60B | $4.07B | $3.62B |
| Net Income | $912.9M | $912.9M | $857.8M | $743.6M | $647.7M |
| EBITDA | $1.37B | $1.37B | $1.31B | $1.12B | $978.7M |
| EPS | 379.61 | 379.61 | 356.47 | 309.31 | 269.64 |
| Gross Margin | 39.0% | 39.0% | 42.2% | 39.0% | 39.8% |
| Operating Margin | 24.5% | 24.5% | 27.7% | 26.7% | 26.6% |
| Net Margin | 17.1% | 17.1% | 18.7% | 18.3% | 17.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Current Ratio | 7.81 | 7.81 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.09B | $1.09B | $685.0M | $452.3M | $706.1M |
| Returns | |||||
| ROE | 21.2% | 21.2% | 24.1% | 26.5% | 30.2% |
| Valuation | |||||
| P/E | 9.10 | 9.10 | 13.03 | 15.57 | 20.40 |
| EV/EBITDA | 2.00 | 2.00 | 6.54 | 8.57 | 11.60 |
| P/B | 1.44 | 1.44 | 3.14 | 4.13 | 6.15 |
| Growth & Yield | |||||
| Revenue Growth | 15.9% | 15.9% | 12.9% | 12.6% | — |
| EPS Growth | 6.5% | 6.5% | 15.2% | 14.7% | — |
| Dividend Yield | 7.8% | 7.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-15.6%
EPS terminal req.
$228.04
Spread vs growth
22.1%
5Y implied EPS CAGR
-6.2%
EPS terminal req.
$275.93
Spread vs growth
12.7%
10Y implied EPS CAGR
1.6%
EPS terminal req.
$444.39
Spread vs growth
4.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-3.4%
Start / end P/E
8.1x → 6.7x
EPS bridge
356.47 → 379.61
Residual
-1.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.